Table 3

Explained variation in therapeutic warfarin dose pooled models

Predictor/predictor groupAdjusted R2
Clinical only 0.17 
Clinical plus CYP2C9 and VKORC1 0.54 
Clinical plus CYP2C9 and VKORC1 and CYP4F2 0.56 
Predictor/predictor groupAdjusted R2
Clinical only 0.17 
Clinical plus CYP2C9 and VKORC1 0.54 
Clinical plus CYP2C9 and VKORC1 and CYP4F2 0.56 

Clinical variables were sex, age, body surface area, and target international normalized ratio.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal